Journal of Regulatory Affairs, January-February 2026
Journal ArticleRenée Matthews
Advanced therapies/cell and gene therapyAdvertising, Promotion and LabelingAsiaBiologics/ biosimilars/ vaccinesChemistry, Manufacturing and Controls (CMC)Clinical TrialsDigital health/SaMD/AIDiversityEuropeGlobalMedical DevicesOTCPharmaceuticalsPharmacovigilanceProduct LifecycleRegulatory harmonizationUnited States